Sri Lanka vs Turkmenistan: Previously treated cases tested for RR-/MDR-TB
Sri Lanka
100.0%
in 2024
Turkmenistan
100.0%
in 2022
Sri Lanka rank
1st
Turkmenistan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Sri Lanka
- Turkmenistan
How they compare
Sri Lanka currently reports 100.0% against 100.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2006 it was Sri Lanka ahead.
Sri Lanka ranks 1st and Turkmenistan ranks 1st of 180 countries.
Across the 3 decades both report, Sri Lanka averaged higher in 2 and Turkmenistan in 1.
Head to head by decade
| Decade | Sri Lanka | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.0% | 42.0% | 35.0% | Sri Lanka |
| 2010s | 99.5% | 55.0% | 44.5% | Sri Lanka |
| 2020s | 85.0% | 100.0% | 15.0% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sri Lanka or Turkmenistan?
- Sri Lanka, at 100.0% against 100.0% in Turkmenistan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sri Lanka and Turkmenistan?
- 0.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Turkmenistan?
- 5 years are reported by both, from 2006 to 2022.
- How do Sri Lanka and Turkmenistan rank globally for previously treated cases tested for rr-/mdr-tb?
- Sri Lanka ranks 1st and Turkmenistan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.